Last reviewed · How we verify
ART only arm
ART (antiretroviral therapy) only arm refers to HIV treatment using combination antiretroviral drugs without additional interventions.
ART (antiretroviral therapy) only arm refers to HIV treatment using combination antiretroviral drugs without additional interventions. Used for HIV-1 infection (standard antiretroviral therapy).
At a glance
| Generic name | ART only arm |
|---|---|
| Sponsor | Prof JMA Lange |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease / Virology |
| Phase | FDA-approved |
Mechanism of action
This represents a control or standard-of-care arm in clinical trials where patients receive antiretroviral therapy alone to suppress HIV replication. It serves as a comparator to experimental treatment strategies that may combine ART with immunotherapies, therapeutic vaccines, or other adjunctive approaches.
Approved indications
- HIV-1 infection (standard antiretroviral therapy)
Common side effects
Key clinical trials
- Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India (NA)
- The Impact of Music Medicine on Preterm Brain Development and Behavior (NA)
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) (PHASE2)
- The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY (NA)
- REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE: A Multi-Center, Single-Arm, Open-Label, Phase 4 Study Assessing the Safety and Efficacy of B/F/TAF in HIV-Positive Adults Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks (PHASE4)
- POP SINGER Pilot Study (NA)
- Getting to Zero Among HHI MSM in the American South (NA)
- EXPRESSIVE ARTS THERAPY FOR HOPE IN PEOPLE WITH SCHIZOPHRENIA (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ART only arm CI brief — competitive landscape report
- ART only arm updates RSS · CI watch RSS
- Prof JMA Lange portfolio CI